Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 100 participants.

Also called NCT03584217

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 1/2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03584217
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03584217. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-10-01 (actual); primary completion 2023-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
Acronym
Renal-HEIR
Condition
Type 2 Diabetes Mellitus
Condition
Obesity
Condition
Nephropathy
Condition
Adolescent Obesity
Intervention (Drug)
Aminohippurate Sodium Inj 20%
Intervention (Drug)
Iohexol Inj 300 MG/ML
Intervention (Procedure)
Renal Biopsy
Lead sponsor
University of Colorado, Denver (class: other)

Record details

Record id
cardio:ct-nct03584217
Content hash
6bff78b9da1fde672b06232640f5f4ff9c111a76a73ce8fdeccccb6293339a36